JAGUAR HEALTH INC Chart calendar Jaguar Health Inc
9482b7b3084a.61WDX8Vs-jTCmg8-zudvACrSJs_-cUaoR98KEGspIAY.2jfWCqIUgF7y8VVQjYsDR3mQdYXIBhmcBetDJxNqS2mBYeQSj13XdqStPw~690e24e0e1ae9ffb6dc83db5fdd538f6
Upcoming events on Jaguar Health Inc
Past events on Jaguar Health Inc
| 2024-04-23 | Oncology Nursing Society Congress |
| 2024-04-08 | Extraordinary Shareholders Meeting |
| 2024-04-01 08:30 | Q4 2023 Earnings Call |
| 2024-04-01 08:00 | Q4 2023 Earnings Release |
| 2024-02-01 15:30 | Lytham Partners Investor Select Conference |
| 2024-01-31 10:25 | The Microcap Conference |
| 2024-01-29 | The DealFlow Microcap Conference |
| 2023-12-05 12:55 | MedInvest Oncology Investor Conference |
| 2023-11-14 08:30 | Q3 2023 Earnings Call |
| 2023-11-14 08:00 | Q3 2023 Earnings Release |
| 2023-11-05 | BIO-Europe Conference |
| 2023-11-01 12:00 | Emerging Growth Virtual Conference |
| 2023-10-29 | World Orphan Drug Congress |
| 2023-10-24 | Association of Nurses in AIDS Care Conference |
| 2023-10-18 11:45 | BIO Investor Forum |
| 2023-10-17 07:00 | Lytham Partners Fall Investor Conference |
| 2023-10-11 | Veterinary Cancer Society Conference |
| 2023-10-04 | Global Capital Network Investor Conference |
| 2023-10-03 15:00 | LD Micro Main Conference |
| 2023-09-11 07:00 | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5,78 7,12 -18.84% | 9,39 9,17 2.34% | 4,34 10,7 -59.33% | 12,0 11,9 0.22% | 0,00 | 15,1 |
|
EBITDA Million USD | Released Forecast Spread | -22,6 -17,7 -27.43% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -24,3 -25,6 5.17% | -26,6 -28,1 5.27% | -40,7 -33,4 -21.83% | -34,4 -33,5 -2.64% | 0,00 | -23,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -38,5 -35,6 -8.27% | -33,8 -31,6 -7.02% | -52,6 -42,5 -23.85% | -48,4 -44,1 -9.86% | 0,00 | -26,3 |
|
Net income Million USD | Released Forecast Spread | -44,7 -34,2 -30.76% | -38,6 -31,6 -22.34% | -52,6 -42,5 -23.84% | -47,5 -44,1 -7.73% | -41,3 | -26,3 |
|
EPS USD | Released Forecast Spread | -2 027 -1 342 -51.05% | -225 -191 -17.65% | -88,5 -54,4 -62.76% | -36,2 -39,0 7.23% | -1,79 | -0,09 |
| Announcement Date | 03/04/20 | 31/03/21 | 11/03/22 | 24/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,08 8,40 -75.24% | 2,63 1,62 62.04% | 2,92 3,10 -5.77% | 3,15 3,53 -10.76% | 3,26 3,32 -1.81% | 2,68 2,28 17.37% | 2,81 2,46 14.35% | 2,96 | 4,01 | 4,22 | 3,92 | 4,44 | |
|
EBIT Million USD | Released Forecast Spread | -10,8 -3,53 -207.01% | -11,8 -9,20 -27.76% | -6,48 -9,40 31.07% | -9,90 -8,54 -15.88% | -6,29 -7,72 18.58% | -8,10 -8,61 5.9% | -8,79 -8,01 -9.7% | -7,16 | -6,11 | -6,32 | -4,28 | -6,30 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,3 -4,23 -238.89% | -18,2 -9,65 -88.23% | -9,39 -9,80 4.18% | -12,6 -8,99 -40.26% | -8,23 -8,32 1.06% | -12,3 -9,21 -33.45% | -7,90 -8,61 8.2% | -7,76 | -6,71 | -6,92 | -4,88 | -6,90 | |
|
Net income Million USD | Released Forecast Spread | -14,3 -4,23 -238.77% | -18,0 -9,65 -86.38% | -9,37 -9,80 4.42% | -12,5 -8,99 -39.27% | -7,58 -8,32 8.88% | -12,2 | -12,2 -9,21 -31.92% | -7,78 -8,61 9.66% | -7,76 | -6,71 | -6,92 | -4,88 | -6,90 |
|
EPS USD | Released Forecast Spread | -23,3 -6,75 -244.44% | -30,0 -13,1 -128.57% | -9,00 -16,5 45.45% | -9,00 -5,63 -60% | -5,25 | -2,39 | -0,69 -1,53 54.9% | -0,38 -1,23 69.11% | -0,03 | -0,02 | -0,02 | -0,02 | -0,02 |
| Announcement Date | 11/03/22 | 10/05/22 | 22/08/22 | 14/11/22 | 24/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | - | - | - | - | - |
More events